LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

UNH

321.58

+1.9%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

UNH

321.58

+1.9%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

UNH

321.58

+1.9%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

UNH

321.58

+1.9%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

UNH

321.58

+1.9%↑

Search

DaVita Inc

Geschlossen

BrancheGesundheitswesen

145.58 0.43

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

144.4

Max

147.6

Schlüsselkennzahlen

By Trading Economics

Einkommen

-117M

232M

Verkäufe

-71M

3.2B

KGV

Branchendurchschnitt

14.395

54.533

EPS

2

Gewinnspanne

7.204

Angestellte

76,000

EBITDA

-131M

598M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+9.51% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.5B

11B

Vorheriger Eröffnungskurs

145.15

Vorheriger Schlusskurs

145.58

Nachrichtenstimmung

By Acuity

29%

71%

80 / 382 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

DaVita Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Feb. 2025, 19:50 UTC

Wichtige Markttreiber

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21. März 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

15. Juli 2024, 08:17 UTC

Market Talk

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Peer-Vergleich

Kursveränderung

DaVita Inc Prognose

Kursziel

By TipRanks

9.51% Vorteil

12-Monats-Prognose

Durchschnitt 158.75 USD  9.51%

Hoch 169 USD

Tief 145 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für DaVita Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

4 ratings

0

Buy

3

Halten

1

Sell

Technischer Score

By Trading Central

142.36 / 144.275Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

80 / 382 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.